XKRX:291650 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
896
+12 (+1.36%)
Apr 11
What is a stock summary page? Click here for an overview.
Business Description
Aptamer Sciences Inc
ISIN : KR7291650000
Share Class Description:
XKRX:291650: Ordinary SharesCompare
Compare
Traded in other countries / regions
291650.Korea Index Membership
KOSDAQ Composite Index IPO Date
2020-09-16Description
Aptamer Sciences Inc is a research and development based bio venture company. The company is focused on the Aptamer Technology Platform for the development of innovative therapeutic and diagnostic platforms. It develops and facilitates drug development and other diagnostic products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.82 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.3 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -0.84 | |||||
| Beneish M-Score | 3.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 67.8 | |||||
| 3-Year EBITDA Growth Rate | -31.2 | |||||
| 3-Year EPS without NRI Growth Rate | -32.4 | |||||
| 3-Year FCF Growth Rate | 7.8 | |||||
| 3-Year Book Growth Rate | -18.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.3 | |||||
| 9-Day RSI | 46.87 | |||||
| 14-Day RSI | 44.97 | |||||
| 3-1 Month Momentum % | -19.72 | |||||
| 6-1 Month Momentum % | -61.77 | |||||
| 12-1 Month Momentum % | -60.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.84 | |||||
| Quick Ratio | 4.83 | |||||
| Cash Ratio | 4.49 | |||||
| Days Inventory | 61.31 | |||||
| Days Sales Outstanding | 31.73 | |||||
| Days Payable | 13.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.4 | |||||
| Shareholder Yield % | -67.96 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.3 | |||||
| Operating Margin % | -651.23 | |||||
| Net Margin % | -803.68 | |||||
| FCF Margin % | -650.07 | |||||
| ROE % | -58.14 | |||||
| ROA % | -27.59 | |||||
| ROIC % | -29.57 | |||||
| 3-Year ROIIC % | -38.05 | |||||
| ROC (Joel Greenblatt) % | -82.59 | |||||
| ROCE % | -42.14 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 23.39 | |||||
| PB Ratio | 1.08 | |||||
| Price-to-Tangible-Book | 1.17 | |||||
| EV-to-EBIT | -1.63 | |||||
| EV-to-EBITDA | -1.81 | |||||
| EV-to-Revenue | 11.08 | |||||
| EV-to-FCF | -1.39 | |||||
| Price-to-GF-Value | 0.08 | |||||
| Price-to-Net-Current-Asset-Value | 2.29 | |||||
| Price-to-Net-Cash | 2.47 | |||||
| Earnings Yield (Greenblatt) % | -61.38 | |||||
| FCF Yield % | -26.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptamer Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 1,082.812 | ||
| EPS (TTM) (â‚©) | -494.818 | ||
| Beta | -0.15 | ||
| 3-Year Sharpe Ratio | -0.86 | ||
| 3-Year Sortino Ratio | -1.05 | ||
| Volatility % | 61.85 | ||
| 14-Day RSI | 44.97 | ||
| 14-Day ATR (â‚©) | 46.743895 | ||
| 20-Day SMA (â‚©) | 917.5 | ||
| 12-1 Month Momentum % | -60.57 | ||
| 52-Week Range (â‚©) | 803 - 3281.406608 | ||
| Shares Outstanding (Mil) | 30.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aptamer Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aptamer Sciences Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aptamer Sciences Inc Frequently Asked Questions
What is Aptamer Sciences Inc(XKRX:291650)'s stock price today?
The current price of XKRX:291650 is â‚©896.00. The 52 week high of XKRX:291650 is â‚©3281.41 and 52 week low is â‚©803.00.
When is next earnings date of Aptamer Sciences Inc(XKRX:291650)?
The next earnings date of Aptamer Sciences Inc(XKRX:291650) is .
Does Aptamer Sciences Inc(XKRX:291650) pay dividends? If so, how much?
Aptamer Sciences Inc(XKRX:291650) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers